Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

Overview of attention for article published in New England Journal of Medicine, October 2008

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users
patent: 4 patents

reddit: 2 Redditors
guideline: 4 clinical guideline sources
podcasts: 1 podcast

Readers on

mendeley: 146 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,164 followers.

@glasscatfish 今回、HIV治療のための遺伝子置換の標的となったCCR5に対しては、既にファイザーのマラビロクが日本でも2009年に承認されている。 https://t.co/VgRoDWNNqb NEJM http://t.co/MFxqMjunue

@glasscatfish 今回、HIV治療のための遺伝子置換の標的となったCCR5に対しては、既にファイザーのマラビロクが日本でも2009年に承認されている。 https://t.co/VgRoDWNNqb NEJM http://t.co/MFxqMjunue

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.